デフォルト表紙
市場調査レポート
商品コード
1069315

放射線皮膚炎:世界市場の展望(2021年~2028年)

Radiodermatitis - Global Market Outlook (2021-2028)

出版日: | 発行: Stratistics Market Research Consulting | ページ情報: 英文 200+ Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=136.22円
放射線皮膚炎:世界市場の展望(2021年~2028年)
出版日: 2022年04月01日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の放射線皮膚炎の市場規模は、2021年の5億757万米ドルから、2028年までに7億6,824万米ドルに達し、予測期間中に6.1%のCAGRで成長が予測されています。

当レポートでは、世界の放射線皮膚炎市場について調査分析し、市場動向分析、セグメント別・地域別の市場情報、企業プロファイルなどを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 序文

第3章 市場動向分析

  • 促進要因
  • 抑制要因
  • 市場機会
  • 脅威
  • 製品分析
  • 新興市場
  • COVID-19の影響

第4章 ポーターのファイブフォース分析

第5章 世界の放射線皮膚炎市場:製品別

  • シルバーリーフドレッシング
  • ヒドロゲル・ハイドロコロイドドレッシング
  • ノンスティングバリアフィルム
  • 親水性クリーム
  • 抗生物質
  • はちみつ含浸ガーゼ
  • GM-CSFガーゼ
  • コルチコステロイド
  • シリコーン被覆ドレッシング

第6章 世界の放射線皮膚炎市場:投与経路別

  • 経口
    • 経口コルチコステロイド
    • 鎮痛・抗炎症
  • 局所
    • 局所抗生物質
    • 親水性クリーム
    • 局所コルチコステロイド

第7章 世界の放射線皮膚炎市場:流通チャネル別

  • 小売薬局
  • 研究機関
  • オンライン薬局
  • 病院
  • がん専門クリニック

第8章 世界の放射線皮膚炎市場:地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン
    • その他欧州
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • ニュージーランド
    • 韓国
    • その他アジア太平洋
  • 南米
    • アルゼンチン
    • ブラジル
    • チリ
    • その他南米
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • カタール
    • 南アフリカ
    • その他中東・アフリカ

第9章 主な発展

  • 契約・パートナーシップ・提携・共同事業
  • 買収・合併
  • 新製品の発売
  • 拡張
  • その他の重要な戦略

第10章 企業プロファイル

  • 3M
  • The Jackson Laboratory
  • Stratpharma AG
  • Smith & Nephew
  • Molnlycke Health Care AB
  • LETI Pharma
  • KeraNetics, Inc
  • KCI Licensing Inc
  • InterMed S.A.
  • HARTMANN
  • ConvaTec
  • Charles River Laboratories
  • AceTech
  • Integra LifeSciences Holdings Corporation
図表

List of Tables

  • Table 1 Global Radiodermatitis Market Outlook, By Region (2020-2028) ($MN)
  • Table 2 Global Radiodermatitis Market Outlook, By Product (2020-2028) ($MN)
  • Table 3 Global Radiodermatitis Market Outlook, By Silver Leaf Dressing (2020-2028) ($MN)
  • Table 4 Global Radiodermatitis Market Outlook, By Hydrogel & Hydrocolloid Dressing (2020-2028) ($MN)
  • Table 5 Global Radiodermatitis Market Outlook, By No-Sting Barrier Film (2020-2028) ($MN)
  • Table 6 Global Radiodermatitis Market Outlook, By Hydrophilic Creams (2020-2028) ($MN)
  • Table 7 Global Radiodermatitis Market Outlook, By Antibiotics (2020-2028) ($MN)
  • Table 8 Global Radiodermatitis Market Outlook, By Honey Impregnated Gauze (2020-2028) ($MN)
  • Table 9 Global Radiodermatitis Market Outlook, By GM-CSF gauze (2020-2028) ($MN)
  • Table 10 Global Radiodermatitis Market Outlook, By Corticosteroids (2020-2028) ($MN)
  • Table 11 Global Radiodermatitis Market Outlook, By Silicone Coated Dressings (2020-2028) ($MN)
  • Table 12 Global Radiodermatitis Market Outlook, By Route of Administration (2020-2028) ($MN)
  • Table 13 Global Radiodermatitis Market Outlook, By Oral (2020-2028) ($MN)
  • Table 14 Global Radiodermatitis Market Outlook, By Oral Corticosteroids (2020-2028) ($MN)
  • Table 15 Global Radiodermatitis Market Outlook, By Analgesic & Anti-Inflammatory (2020-2028) ($MN)
  • Table 16 Global Radiodermatitis Market Outlook, By Topical (2020-2028) ($MN)
  • Table 17 Global Radiodermatitis Market Outlook, By Topical Antibiotics (2020-2028) ($MN)
  • Table 18 Global Radiodermatitis Market Outlook, By Hydrophilic Creams (2020-2028) ($MN)
  • Table 19 Global Radiodermatitis Market Outlook, By Topical Corticosteroids (2020-2028) ($MN)
  • Table 20 Global Radiodermatitis Market Outlook, By Distribution Channel (2020-2028) ($MN)
  • Table 21 Global Radiodermatitis Market Outlook, By Retail Pharmacy (2020-2028) ($MN)
  • Table 22 Global Radiodermatitis Market Outlook, By Research Institutes (2020-2028) ($MN)
  • Table 23 Global Radiodermatitis Market Outlook, By Online Pharmacy (2020-2028) ($MN)
  • Table 24 Global Radiodermatitis Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 25 Global Radiodermatitis Market Outlook, By Cancer Specialist Clinics (2020-2028) ($MN)
  • Table 26 North America Radiodermatitis Market Outlook, By Country (2020-2028) ($MN)
  • Table 27 North America Radiodermatitis Market Outlook, By Product (2020-2028) ($MN)
  • Table 28 North America Radiodermatitis Market Outlook, By Silver Leaf Dressing (2020-2028) ($MN)
  • Table 29 North America Radiodermatitis Market Outlook, By Hydrogel & Hydrocolloid Dressing (2020-2028) ($MN)
  • Table 30 North America Radiodermatitis Market Outlook, By No-Sting Barrier Film (2020-2028) ($MN)
  • Table 31 North America Radiodermatitis Market Outlook, By Hydrophilic Creams (2020-2028) ($MN)
  • Table 32 North America Radiodermatitis Market Outlook, By Antibiotics (2020-2028) ($MN)
  • Table 33 North America Radiodermatitis Market Outlook, By Honey Impregnated Gauze (2020-2028) ($MN)
  • Table 34 North America Radiodermatitis Market Outlook, By GM-CSF gauze (2020-2028) ($MN)
  • Table 35 North America Radiodermatitis Market Outlook, By Corticosteroids (2020-2028) ($MN)
  • Table 36 North America Radiodermatitis Market Outlook, By Silicone Coated Dressings (2020-2028) ($MN)
  • Table 37 North America Radiodermatitis Market Outlook, By Route of Administration (2020-2028) ($MN)
  • Table 38 North America Radiodermatitis Market Outlook, By Oral (2020-2028) ($MN)
  • Table 39 North America Radiodermatitis Market Outlook, By Oral Corticosteroids (2020-2028) ($MN)
  • Table 40 North America Radiodermatitis Market Outlook, By Analgesic & Anti-Inflammatory (2020-2028) ($MN)
  • Table 41 North America Radiodermatitis Market Outlook, By Topical (2020-2028) ($MN)
  • Table 42 North America Radiodermatitis Market Outlook, By Topical Antibiotics (2020-2028) ($MN)
  • Table 43 North America Radiodermatitis Market Outlook, By Hydrophilic Creams (2020-2028) ($MN)
  • Table 44 North America Radiodermatitis Market Outlook, By Topical Corticosteroids (2020-2028) ($MN)
  • Table 45 North America Radiodermatitis Market Outlook, By Distribution Channel (2020-2028) ($MN)
  • Table 46 North America Radiodermatitis Market Outlook, By Retail Pharmacy (2020-2028) ($MN)
  • Table 47 North America Radiodermatitis Market Outlook, By Research Institutes (2020-2028) ($MN)
  • Table 48 North America Radiodermatitis Market Outlook, By Online Pharmacy (2020-2028) ($MN)
  • Table 49 North America Radiodermatitis Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 50 North America Radiodermatitis Market Outlook, By Cancer Specialist Clinics (2020-2028) ($MN)
  • Table 51 Europe Radiodermatitis Market Outlook, By Country (2020-2028) ($MN)
  • Table 52 Europe Radiodermatitis Market Outlook, By Product (2020-2028) ($MN)
  • Table 53 Europe Radiodermatitis Market Outlook, By Silver Leaf Dressing (2020-2028) ($MN)
  • Table 54 Europe Radiodermatitis Market Outlook, By Hydrogel & Hydrocolloid Dressing (2020-2028) ($MN)
  • Table 55 Europe Radiodermatitis Market Outlook, By No-Sting Barrier Film (2020-2028) ($MN)
  • Table 56 Europe Radiodermatitis Market Outlook, By Hydrophilic Creams (2020-2028) ($MN)
  • Table 57 Europe Radiodermatitis Market Outlook, By Antibiotics (2020-2028) ($MN)
  • Table 58 Europe Radiodermatitis Market Outlook, By Honey Impregnated Gauze (2020-2028) ($MN)
  • Table 59 Europe Radiodermatitis Market Outlook, By GM-CSF gauze (2020-2028) ($MN)
  • Table 60 Europe Radiodermatitis Market Outlook, By Corticosteroids (2020-2028) ($MN)
  • Table 61 Europe Radiodermatitis Market Outlook, By Silicone Coated Dressings (2020-2028) ($MN)
  • Table 62 Europe Radiodermatitis Market Outlook, By Route of Administration (2020-2028) ($MN)
  • Table 63 Europe Radiodermatitis Market Outlook, By Oral (2020-2028) ($MN)
  • Table 64 Europe Radiodermatitis Market Outlook, By Oral Corticosteroids (2020-2028) ($MN)
  • Table 65 Europe Radiodermatitis Market Outlook, By Analgesic & Anti-Inflammatory (2020-2028) ($MN)
  • Table 66 Europe Radiodermatitis Market Outlook, By Topical (2020-2028) ($MN)
  • Table 67 Europe Radiodermatitis Market Outlook, By Topical Antibiotics (2020-2028) ($MN)
  • Table 68 Europe Radiodermatitis Market Outlook, By Hydrophilic Creams (2020-2028) ($MN)
  • Table 69 Europe Radiodermatitis Market Outlook, By Topical Corticosteroids (2020-2028) ($MN)
  • Table 70 Europe Radiodermatitis Market Outlook, By Distribution Channel (2020-2028) ($MN)
  • Table 71 Europe Radiodermatitis Market Outlook, By Retail Pharmacy (2020-2028) ($MN)
  • Table 72 Europe Radiodermatitis Market Outlook, By Research Institutes (2020-2028) ($MN)
  • Table 73 Europe Radiodermatitis Market Outlook, By Online Pharmacy (2020-2028) ($MN)
  • Table 74 Europe Radiodermatitis Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 75 Europe Radiodermatitis Market Outlook, By Cancer Specialist Clinics (2020-2028) ($MN)
  • Table 76 Asia Pacific Radiodermatitis Market Outlook, By Country (2020-2028) ($MN)
  • Table 77 Asia Pacific Radiodermatitis Market Outlook, By Product (2020-2028) ($MN)
  • Table 78 Asia Pacific Radiodermatitis Market Outlook, By Silver Leaf Dressing (2020-2028) ($MN)
  • Table 79 Asia Pacific Radiodermatitis Market Outlook, By Hydrogel & Hydrocolloid Dressing (2020-2028) ($MN)
  • Table 80 Asia Pacific Radiodermatitis Market Outlook, By No-Sting Barrier Film (2020-2028) ($MN)
  • Table 81 Asia Pacific Radiodermatitis Market Outlook, By Hydrophilic Creams (2020-2028) ($MN)
  • Table 82 Asia Pacific Radiodermatitis Market Outlook, By Antibiotics (2020-2028) ($MN)
  • Table 83 Asia Pacific Radiodermatitis Market Outlook, By Honey Impregnated Gauze (2020-2028) ($MN)
  • Table 84 Asia Pacific Radiodermatitis Market Outlook, By GM-CSF gauze (2020-2028) ($MN)
  • Table 85 Asia Pacific Radiodermatitis Market Outlook, By Corticosteroids (2020-2028) ($MN)
  • Table 86 Asia Pacific Radiodermatitis Market Outlook, By Silicone Coated Dressings (2020-2028) ($MN)
  • Table 87 Asia Pacific Radiodermatitis Market Outlook, By Route of Administration (2020-2028) ($MN)
  • Table 88 Asia Pacific Radiodermatitis Market Outlook, By Oral (2020-2028) ($MN)
  • Table 89 Asia Pacific Radiodermatitis Market Outlook, By Oral Corticosteroids (2020-2028) ($MN)
  • Table 90 Asia Pacific Radiodermatitis Market Outlook, By Analgesic & Anti-Inflammatory (2020-2028) ($MN)
  • Table 91 Asia Pacific Radiodermatitis Market Outlook, By Topical (2020-2028) ($MN)
  • Table 92 Asia Pacific Radiodermatitis Market Outlook, By Topical Antibiotics (2020-2028) ($MN)
  • Table 93 Asia Pacific Radiodermatitis Market Outlook, By Hydrophilic Creams (2020-2028) ($MN)
  • Table 94 Asia Pacific Radiodermatitis Market Outlook, By Topical Corticosteroids (2020-2028) ($MN)
  • Table 95 Asia Pacific Radiodermatitis Market Outlook, By Distribution Channel (2020-2028) ($MN)
  • Table 96 Asia Pacific Radiodermatitis Market Outlook, By Retail Pharmacy (2020-2028) ($MN)
  • Table 97 Asia Pacific Radiodermatitis Market Outlook, By Research Institutes (2020-2028) ($MN)
  • Table 98 Asia Pacific Radiodermatitis Market Outlook, By Online Pharmacy (2020-2028) ($MN)
  • Table 99 Asia Pacific Radiodermatitis Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 100 Asia Pacific Radiodermatitis Market Outlook, By Cancer Specialist Clinics (2020-2028) ($MN)
  • Table 101 South America Radiodermatitis Market Outlook, By Country (2020-2028) ($MN)
  • Table 102 South America Radiodermatitis Market Outlook, By Product (2020-2028) ($MN)
  • Table 103 South America Radiodermatitis Market Outlook, By Silver Leaf Dressing (2020-2028) ($MN)
  • Table 104 South America Radiodermatitis Market Outlook, By Hydrogel & Hydrocolloid Dressing (2020-2028) ($MN)
  • Table 105 South America Radiodermatitis Market Outlook, By No-Sting Barrier Film (2020-2028) ($MN)
  • Table 106 South America Radiodermatitis Market Outlook, By Hydrophilic Creams (2020-2028) ($MN)
  • Table 107 South America Radiodermatitis Market Outlook, By Antibiotics (2020-2028) ($MN)
  • Table 108 South America Radiodermatitis Market Outlook, By Honey Impregnated Gauze (2020-2028) ($MN)
  • Table 109 South America Radiodermatitis Market Outlook, By GM-CSF gauze (2020-2028) ($MN)
  • Table 110 South America Radiodermatitis Market Outlook, By Corticosteroids (2020-2028) ($MN)
  • Table 111 South America Radiodermatitis Market Outlook, By Silicone Coated Dressings (2020-2028) ($MN)
  • Table 112 South America Radiodermatitis Market Outlook, By Route of Administration (2020-2028) ($MN)
  • Table 113 South America Radiodermatitis Market Outlook, By Oral (2020-2028) ($MN)
  • Table 114 South America Radiodermatitis Market Outlook, By Oral Corticosteroids (2020-2028) ($MN)
  • Table 115 South America Radiodermatitis Market Outlook, By Analgesic & Anti-Inflammatory (2020-2028) ($MN)
  • Table 116 South America Radiodermatitis Market Outlook, By Topical (2020-2028) ($MN)
  • Table 117 South America Radiodermatitis Market Outlook, By Topical Antibiotics (2020-2028) ($MN)
  • Table 118 South America Radiodermatitis Market Outlook, By Hydrophilic Creams (2020-2028) ($MN)
  • Table 119 South America Radiodermatitis Market Outlook, By Topical Corticosteroids (2020-2028) ($MN)
  • Table 120 South America Radiodermatitis Market Outlook, By Distribution Channel (2020-2028) ($MN)
  • Table 121 South America Radiodermatitis Market Outlook, By Retail Pharmacy (2020-2028) ($MN)
  • Table 122 South America Radiodermatitis Market Outlook, By Research Institutes (2020-2028) ($MN)
  • Table 123 South America Radiodermatitis Market Outlook, By Online Pharmacy (2020-2028) ($MN)
  • Table 124 South America Radiodermatitis Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 125 South America Radiodermatitis Market Outlook, By Cancer Specialist Clinics (2020-2028) ($MN)
  • Table 126 Middle East & Africa Radiodermatitis Market Outlook, By Country (2020-2028) ($MN)
  • Table 127 Middle East & Africa Radiodermatitis Market Outlook, By Product (2020-2028) ($MN)
  • Table 128 Middle East & Africa Radiodermatitis Market Outlook, By Silver Leaf Dressing (2020-2028) ($MN)
  • Table 129 Middle East & Africa Radiodermatitis Market Outlook, By Hydrogel & Hydrocolloid Dressing (2020-2028) ($MN)
  • Table 130 Middle East & Africa Radiodermatitis Market Outlook, By No-Sting Barrier Film (2020-2028) ($MN)
  • Table 131 Middle East & Africa Radiodermatitis Market Outlook, By Hydrophilic Creams (2020-2028) ($MN)
  • Table 132 Middle East & Africa Radiodermatitis Market Outlook, By Antibiotics (2020-2028) ($MN)
  • Table 133 Middle East & Africa Radiodermatitis Market Outlook, By Honey Impregnated Gauze (2020-2028) ($MN)
  • Table 134 Middle East & Africa Radiodermatitis Market Outlook, By GM-CSF gauze (2020-2028) ($MN)
  • Table 135 Middle East & Africa Radiodermatitis Market Outlook, By Corticosteroids (2020-2028) ($MN)
  • Table 136 Middle East & Africa Radiodermatitis Market Outlook, By Silicone Coated Dressings (2020-2028) ($MN)
  • Table 137 Middle East & Africa Radiodermatitis Market Outlook, By Route of Administration (2020-2028) ($MN)
  • Table 138 Middle East & Africa Radiodermatitis Market Outlook, By Oral (2020-2028) ($MN)
  • Table 139 Middle East & Africa Radiodermatitis Market Outlook, By Oral Corticosteroids (2020-2028) ($MN)
  • Table 140 Middle East & Africa Radiodermatitis Market Outlook, By Analgesic & Anti-Inflammatory (2020-2028) ($MN)
  • Table 141 Middle East & Africa Radiodermatitis Market Outlook, By Topical (2020-2028) ($MN)
  • Table 142 Middle East & Africa Radiodermatitis Market Outlook, By Topical Antibiotics (2020-2028) ($MN)
  • Table 143 Middle East & Africa Radiodermatitis Market Outlook, By Hydrophilic Creams (2020-2028) ($MN)
  • Table 144 Middle East & Africa Radiodermatitis Market Outlook, By Topical Corticosteroids (2020-2028) ($MN)
  • Table 145 Middle East & Africa Radiodermatitis Market Outlook, By Distribution Channel (2020-2028) ($MN)
  • Table 146 Middle East & Africa Radiodermatitis Market Outlook, By Retail Pharmacy (2020-2028) ($MN)
  • Table 147 Middle East & Africa Radiodermatitis Market Outlook, By Research Institutes (2020-2028) ($MN)
  • Table 148 Middle East & Africa Radiodermatitis Market Outlook, By Online Pharmacy (2020-2028) ($MN)
  • Table 149 Middle East & Africa Radiodermatitis Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 150 Middle East & Africa Radiodermatitis Market Outlook, By Cancer Specialist Clinics (2020-2028) ($MN)
目次
Product Code: SMRC21377

According to Stratistics MRC, the Global Radiodermatitis Market is accounted for $507.57 million in 2021 and is expected to reach $768.24 million by 2028 growing at a CAGR of 6.1% during the forecast period. Radiodermatitis is the skin condition observed in the individuals undergoing radiation therapy used for the cancer treatment or certain skin disorders. The general symptoms associated with radiation burns include itching, redness, flaking, peeling, soreness, blisters, and others. Cumulative daily doses of radiation to the treatment field or target site on the body inhibits normal skin repopulation and fades skin integrity at and around the radiation field.

Market Dynamics:

Driver:

Increasing Prevalence of Cancer

The rate of certain types of cancers such as breast cancer and head and neck cancer is projected to rise. This is attributable to faulty lifestyle factors such as obesity for breast cancer, and smoking for head and neck cancers. These kinds of cancers are treated with radiation at site. So, patients suffering from these cancers are more likely to develop radiation-induced dermatitis. Therefore, the overall spiral in cancer cases coupled with a surge in specific cancers due to faulty lifestyle is likely to propel the radiodermatitis market.

Restraint:

Higher Radiodermatitis Cost

High cost radiodermatitis products may negatively impact the radiodermatitis market, in the coming years. The burden of cost of cancer treatment is a concern in developing nations, where high cost of therapy leads to constraints in financial resources. So, high cost of products, especially dressings such as honey-impregnated dressings and silicone dressings, is likely to restrain the market.

Opportunity:

Significant expansion of healthcare establishments

Many countries have experienced the expansion of biotechnology & pharmaceutical companies in the recent years. The extensively increasing awareness among Asian consumers regarding enhancing the quality of life has also increased. In addition to this, burden of various chronic conditions including skin cancer and breast cancer is extremely increasing in the APAC region. Thereby the consumption and constant growth of radiodermatitis in this region has increased, which can create the market opportunities for global radiodermatitis industry.

Threat:

Introduction of better radiation therapy equipment

The severity and likeliness to develop radiodermatitis can be either patient-related or treatment-related. The treatment-related factors include the type and quality of radiation beam and the location and size of the treatment field. Modern radiotherapy techniques, which include intensity-modulated radiation therapy (IMRT) and proton therapy, can diminish the risk for radiodermatitis by more accurately targeting tumor. Such scenario is expected to act as a threat to the growth of the market.

The topical segment is expected to be the largest during the forecast period

The topical segment is estimated to have a lucrative growth due to the easier application, cost-effectiveness, and its bioavailability. Topical products reduce the risk of microbial transmission and shield the skin against abrasive materials. Moreover, presence of a broad range of topical products including topical antibiotics, corticosteroids, and hydrophilic creams as well as surge in the demand for modern wound care options are some of the major factors accelerating the growth of the segment.

The online pharmacy segment is expected to have the highest CAGR during the forecast period

The online pharmacy segment is anticipated to witness the fastest CAGR growth during the forecast period owing to the various advantages such as increased convenience for patients who're unwilling to purchase medicines from retail or hospital pharmacies. Online pharmacy is an excellent platform which is playing important role in the sales of radiodermatitis medicines.

Region with highest share:

North America is projected to hold the largest market share during the forecast period due to widespread occurrence of cancer and dominant use of radiotherapy for treatment of various types of cancer. Ongoing investments in cancer research, government efforts to boost cancer awareness, and the rise in radiation therapy for cancer treatment will positively impact the regional industry dynamics.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period owing to expanding cancer patient base present across this region and extensive collaborations undertaken by key players for increasing their product portfolio expansion capabilities. Favorable government initiatives that support research activities and an increase in outsourcing by developed economies serve as key growth factors for this region.

Key players in the market

Some of the key players profiled in the Radiodermatitis Market include 3M, The Jackson Laboratory, Stratpharma AG, Smith & Nephew, Molnlycke Health Care AB, LETI Pharma, KeraNetics, Inc, KCI Licensing Inc, InterMed S.A., HARTMANN, ConvaTec, Charles River Laboratories and AceTech.

Key Developments:

In September 2019: Integra LifeSciences Holdings Corporation acquired Rebound Therapeutics. The acquisition of Rebound Therapeutics reflects Integra's ongoing commitment to developing innovative products to address unmet needs in neurosurgery.

In May 2019: 3M acquired Acelity and its KCI subsidiaries. The combination of KCI with 3M will accelerate the reach of a business that is a leader in innovation, customer experience and clinical and economic evidence.

In July 2017: Stratpharma AG launched StrataXRT®, the first and only topical film-forming wound dressing specifically designed to manage radiation dermatitis. StrataXRT is an innovative, flexible wound dressing that helps to promote a moist wound healing environment for rapid healing and faster re-epithelialization, post radiation therapy.

Products Covered:

  • Silver Leaf Dressing
  • Hydrogel & Hydrocolloid Dressing
  • No-Sting Barrier Film
  • Hydrophilic Creams
  • Antibiotics
  • Honey Impregnated Gauze
  • GM-CSF gauze
  • Corticosteroids
  • Silicone Coated Dressings

Route of Administrations Covered:

  • Oral
  • Topical

Distribution Channels Covered:

  • Retail Pharmacy
  • Research Institutes
  • Online Pharmacy
  • Hospitals
  • Cancer Specialist Clinics

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Radiodermatitis Market, By Product

  • 5.1 Introduction
  • 5.2 Silver Leaf Dressing
  • 5.3 Hydrogel & Hydrocolloid Dressing
  • 5.4 No-Sting Barrier Film
  • 5.5 Hydrophilic Creams
  • 5.6 Antibiotics
  • 5.7 Honey Impregnated Gauze
  • 5.8 GM-CSF gauze
  • 5.9 Corticosteroids
  • 5.10 Silicone Coated Dressings

6 Global Radiodermatitis Market, By Route of Administration

  • 6.1 Introduction
  • 6.2 Oral
    • 6.2.1 Oral Corticosteroids
    • 6.2.2 Analgesic & Anti-Inflammatory
  • 6.3 Topical
    • 6.3.1 Topical Antibiotics
    • 6.3.2 Hydrophilic Creams
    • 6.3.3 Topical Corticosteroids

7 Global Radiodermatitis Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Retail Pharmacy
  • 7.3 Research Institutes
  • 7.4 Online Pharmacy
  • 7.5 Hospitals
  • 7.6 Cancer Specialist Clinics

8 Global Radiodermatitis Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 3M
  • 10.2 The Jackson Laboratory
  • 10.3 Stratpharma AG
  • 10.4 Smith & Nephew
  • 10.5 Molnlycke Health Care AB
  • 10.6 LETI Pharma
  • 10.7 KeraNetics, Inc
  • 10.8 KCI Licensing Inc
  • 10.9 InterMed S.A.
  • 10.10 HARTMANN
  • 10.11 ConvaTec
  • 10.12 Charles River Laboratories
  • 10.13 AceTech
  • 10.14 Integra LifeSciences Holdings Corporation